Kathryn C. Zoon, Director at Emergent BioSolutions Inc. (EBS), sold 1,089 shares at $5.78 ($6K) on 2024-05-21, disclosed to the SEC on 2024-05-23.
Seasonal sale ($6k) by Director — this insider has traded EBS in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| EBS | SELL | 2025-03-12 | $115K | — | Filing → |
| EBS | SELL | 2024-06-06 | $61K | — | Filing → |
| EBS | SELL | 2024-05-31 | $8K | — | Filing → |